Form 4 GERON CORP For: Jun 06 Filed by: Kapur Anil
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Geron Corporation (GERN) PT Raised to $6 at Goldman Sachs
June 10, 2024 11:59 AM EDTGoldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $6.00 (from $5.00) while maintaining a Buy rating.
The analyst comments "GERN is trading +19.7% (vs. -1.6% for the XBI) intraday following the FDA approval of Rytelo (imetelstat) in lower-risk myelodysplastic syndrome (LR-MDS).... More



